Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: ZEST II for Osteoporotic Fracture Prevention
Brief Summary: The goal of this study is to perform the first fracture reduction clinical trial with a potent antiresorptive agent (intravenous zoledronic acid) in the most vulnerable long-term care population.